4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-036708
Co-Chief Executive Officer acquired 180,118 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2025-03-06 | Grant or award | +180,118 | 3,376,770 | D | ||
| Derivatives | |||||||
| Cohen Joshua B Co-Chief Executive Officer | 2025-03-06 | Grant or award · Stock Option (Right to Buy) | +270,177 | 270,177 | D | ||
Loading xslF345X05/ownership.xml…